FASLG and autoimmune polyendocrinopathy: Leveraging a highly-sensitive assay for eNOS activity in intact cultured endothelial cells, we identified an mAb directed against β2-GPI that lacks aPL-related actions but blocks cellular responses to pathogenic mAb or polyclonal aPL isolated from APS patients.